RENAISSANCE TECHNOLOGIES LLC

Position in BMEA — Biomea Fusion, Inc.

CIK 1037389 NEW YORK, NY

Position in BMEA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,139,546

+$130,966 QoQ

Shares Held

1,455,474

+10.9% QoQ

Ownership

2.01%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 61 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. BMEA ranks #129 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,139,546	1,455,474	+10.9%	Shares	Sole	2026-08-13
2026-03-31	$2,008,580	1,312,798	+174.3%	Shares	Sole	2026-05-14
2025-12-31	$593,487	478,619	-19.7%	Shares	Sole	2026-02-12
2025-09-30	$1,203,718	595,900	+114.3%	Shares	Sole	2025-11-13
2025-03-31	$592,393	278,119	-19.1%	Shares	Sole	2025-05-14
2024-12-31	$1,333,680	343,732	+317.7%	Shares	Sole	2025-02-13
2024-09-30	$831,230	82,300	-75.0%	Shares	Sole	2024-11-13
2024-06-30	$1,480,977	329,106	+312.4%	Shares	Sole	2024-08-09
2023-03-31	$2,474,598	79,800	+26.7%	Shares	Sole	2023-05-12
2022-12-31	$531,090	63,000	+1.9%	Shares	Sole	2023-02-13
2022-09-30	$604,404	61,800	+25.9%	Shares	Sole	2022-11-14
2022-06-30	$588,218	49,100	+183.8%	Shares	Sole	2022-08-12
2022-03-31	$77,158	17,300	+1.2%	Shares	Sole	2022-05-13
2021-12-31	$127,395	17,100	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.